Cargando…

The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost‐effectiveness analysis

OBJECTIVE: To evaluate the costs and non‐inferiority of a strategy starting with the levonorgestrel intrauterine system (LNG‐IUS) compared with endometrial ablation (EA) in the treatment of heavy menstrual bleeding (HMB). DESIGN: Cost‐effectiveness analysis from a societal perspective alongside a mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Brink, MJ, Beelen, P, Herman, MC, Geomini, PM, Dekker, JH, Vermeulen, KM, Bongers, MY, Berger, MY
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518490/ https://www.ncbi.nlm.nih.gov/pubmed/34245652 http://dx.doi.org/10.1111/1471-0528.16836

Ejemplares similares

Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding
por: Beelen, Pleun, et al.
Publicado: (2021)

Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial
por: Oderkerk, Tamara J., et al.
Publicado: (2022)

Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial
por: Herman, Malou C, et al.
Publicado: (2013)

Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis
por: Roberts, T E, et al.
Publicado: (2011)

Endometrial polypectomy using tissue removal device or electrosurgical snare: a randomised controlled trial
por: van Gemert, J, et al.
Publicado: (2022)

Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
por: Magon, Navneet, et al.
Publicado: (2013)

Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device
por: Creinin, Mitchell D., et al.
Publicado: (2023)

Effect of modified levonorgestrel‐releasing intrauterine system in human adenomyosis with heavy menstrual bleeding
por: Yang, Hong, et al.
Publicado: (2021)

Levonorgestrel intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: A meta-analysis of randomized controlled trials
por: YANG, BING-QING, et al.
Publicado: (2015)

Comparative study of the levonorgestrel intrauterine system and laparoscopic hysterectomy for the treatment of heavy menstrual bleeding in enlarged uteri
por: Depes, Daniella De Batista, et al.
Publicado: (2023)

Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients
por: Middleton, L J, et al.
Publicado: (2010)

Levonorgestrel-releasing intrauterine system for treatment of heavy menstrual bleeding in adolescents with Glanzmann’s Thrombasthenia: illustrated case series
por: Lu, Meiqiu, et al.
Publicado: (2018)

Is 2-dimensional transvaginal ultrasonography necessary 6 weeks after insertion of the levonorgestrel 52-mg intrauterine device?
por: van der Heijden, Patty A.H.H., et al.
Publicado: (2022)

Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system
por: Shawki, Osama, et al.
Publicado: (2013)

Comparison of Bleeding Pattern and Quality of Life Before and After the Insertion of a Levonorgestrel Intrauterine System for Heavy Menstrual Bleeding: A Seven-Year Review
por: Agarwal, Mukta, et al.
Publicado: (2023)

Thermal Balloon Endometrial Ablation in the Treatment of Heavy Menstrual Bleeding
por: Bouzari, Zinatossadat, et al.
Publicado: (2014)

Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial
por: Mawet, Marie, et al.
Publicado: (2014)

Quality of Life of Japanese Dysmenorrhea/Heavy Menstrual Bleeding Patients Treated with Levonorgestrel Intrauterine Delivery System in a Real-World Setting
por: Momoeda, Mikio, et al.
Publicado: (2022)

Effectiveness of Levonorgestrel Releasing Intrauterine System in Perimenopausal Women with Heavy Menstrual Bleeding: A Prospective Study at a Teaching Hospital in India
por: Nidhi,, et al.
Publicado: (2022)

Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial
por: Whitaker, Lucy H.R., et al.
Publicado: (2023)

Modified Thermal Balloon Endometrial Ablation for Treatment of Heavy Menstrual Bleeding
por: Al-Ibrahim, Baraa Lukman Humo, et al.
Publicado: (2022)

Short-term recovery after NovaSure® endometrial ablation: a prospective cohort study
por: Reinders, I.M.A., et al.
Publicado: (2023)

Medically unfit women with early-stage endometrial cancer treated with the levonorgestrel intrauterine system
por: Nikolopoulos, Manolis, et al.
Publicado: (2020)

Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system
por: Steshenko, Alexander, et al.
Publicado: (2021)

Levonorgestrel intrauterine system (Mirena): An emerging tool for conservative treatment of abnormal uterine bleeding
por: Dhamangaonkar, Pallavi C., et al.
Publicado: (2015)

Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
por: Wittmann, Barbara Zantut, et al.
Publicado: (2020)

Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis
por: Daniels, J P, et al.
Publicado: (2012)

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial*
por: Ørbo, A, et al.
Publicado: (2014)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
por: Behnamfar, Fariba, et al.
Publicado: (2014)

Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens
por: Ørbo, A, et al.
Publicado: (2015)

Correction of Phrase: Medically unfit women with earlystage endometrial cancer treated with the levonorgestrel intrauterine system
por: Nikolopoulos, Manolis, et al.
Publicado: (2020)

Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia
por: Shen, Ye, et al.
Publicado: (2022)

Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri)
por: Tosun, Ayse Kavasoglu, et al.
Publicado: (2014)

Are women satisfied when using levonorgestrel-releasing intrauterine system for treatment of abnormal uterine bleeding?
por: Mansukhani, Nina, et al.
Publicado: (2013)

Comparison of Mirena and Liletta levonorgestrel intrauterine devices for the treatment of endometrial intraepithelial neoplasia and grade 1 endometrioid endometrial cancer
por: Chaudhari, Sonal R., et al.
Publicado: (2023)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy
por: Xu, Ling, et al.
Publicado: (2014)

Therapy of heavy menstrual bleeding in Korea: Subanalysis and results from a multinational clinical trial in the Asian region investigating the levonorgestrel-releasing intrauterine system versus conventional therapy
por: Lee, Byung Seok, et al.
Publicado: (2015)

Fertility-Sparing Treatment for Endometrial Cancer: Oncological and Obstetric Outcomes in Combined Therapies with Levonorgestrel Intrauterine Device
por: Pino, Ida, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7gaimu26q32qqqh29ealde46fp